https://www.indianpharmapost.com/evusheld-recommended-for-market-authorisation-in-eu-117382022-03-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/chmp-recommends-eu-approval-of-roches-new-combination-treatment-for-large-b-cell-lymphoma-117482022-03-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/pharmap-2022-to-discuss-contemporary-issues-117472022-03-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/bsv-standardises-on-veeva-vault-promomats-to-speed-content-distribution-117462022-03-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/bar-ilan-university-launches-course-on-3d-printing-in-medicine-117452022-03-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/roche-to-present-data-across-neuroscience-portfolio-at-2022-aan-annual-meeting-117442022-03-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/medtronic-announces-first-patient-implants-for-bladder-incontinence-117432022-03-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/parata-systems-earns-hitrust-certification-117422022-03-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/usfda-approves-janssens-injectable-regimen-for-hiv-117412022-03-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/aquavit-files-ind-with-usfda-for-dtx-021-a-new-botulinum-toxin-117402022-03-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/leadership-changes-at-medgenome-117392022-03-25T00:00:00+05:30always0.9https://www.indianpharmapost.com/japan-approves-bms-breyanzi-application-for-relapsed-large-b-cell-lymphoma-117492022-03-25T00:00:00+05:30always0.9